sur SARTORIUS AG (isin : DE0007165631)
Sartorius Publishes 2025 Annual Report
Sartorius, a prominent player in the life sciences sector, has released its Annual Report for 2025. The report reveals the company's extensive engagement in biopharmaceutical research and manufacturing. Based in Göttingen, Germany, Sartorius supports the industry through its Lab Products & Services and Bioprocess Solutions divisions.
In 2025, Sartorius achieved a sales revenue of approximately 3.5 billion euros, demonstrating its significant role in global biotech drug production. The company operates in around 60 locations worldwide and employs over 14,000 people. Sartorius continues to enrich its offerings with strategic acquisitions, focusing on innovative solutions and technologies.
The company's financial calendar for 2026 includes key dates such as the Annual General Meeting on March 26 and multiple quarter results releases throughout the year.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de SARTORIUS AG